Martin Hey-Mogensen
Director Novo Nordisk
Seminars
Wednesday 28th October 2026
Exploring Energy Expenditure as an Alternative Method of Obesity Treatment
2:30 pm
- Highlighting mode of actions to increase energy expenditure
- Targeting bioenergetics for safe and tolerable increase in energy expenditure to treat metabolic diseases
- Determining which tissue to target to ensure enough efficacy for different therapeutic areas
Wednesday 28th October 2026
Panel & Audience Discussion: Evaluating Oral, Injectable & DNA Delivery Methods to Align Modality Selection with Clinical Performance & Commercial Scale
4:15 pm
- Comparing modality trade-offs in potency, safety and half-life between oral small molecules and injectable peptide therapeutics to guide smarter development decisions
- Exploring how advances in oral delivery and next-generation formats to expand treatment options beyond injectables
- Discussing the manufacturing strengths and pitfalls of oral, DNA and injectable peptide therapies to align delivery mechanisms with commercial viability and faster routes to market
